Related Experiment Video

Updated: May 21, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

[Progressive Multifocal Leukoencephalopathy]

Yoshiharu Miura1

  • 1Department of Neurology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital.

Brain and Nerve = Shinkei Kenkyu No Shinpo
|May 19, 2026
PubMed

Insights

Progressive multifocal leukoencephalopathy (PML), a brain infection from JC polyomavirus (JCV) reactivation, is diagnosed using clinical, imaging, and lab tests. Treatment varies by HIV status, with antiretroviral therapy crucial for HIV-PML cases.

Area of Science:

  • Neurovirology
  • Infectious Diseases
  • Neurology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare, severe central nervous system demyelinating disease.
  • PML is caused by the reactivation of the JC polyomavirus (JCV), a common human virus.
  • Diagnosis involves a combination of clinical presentation, neuroimaging, cerebrospinal fluid analysis, and histopathology.

Purpose of the Study:

  • To outline the diagnostic criteria for PML.
  • To discuss current and emerging treatment strategies for PML.
  • To highlight the importance of differentiating HIV-associated PML from non-HIV PML.

Main Methods:

  • Review of diagnostic modalities including MRI and JCV detection in CSF.
  • Analysis of treatment outcomes for HIV-positive and HIV-negative PML patients.
  • Examination of therapeutic approaches, including antiretroviral therapy and novel antiviral agents.

Main Results:

  • Diagnosis requires integrating clinical, radiological, and laboratory findings.
  • Antiretroviral therapy is the cornerstone of treatment for PML in HIV-infected individuals.
  • Emerging treatments for non-HIV PML include combination therapies and new antiviral drugs.

Conclusions:

  • Accurate diagnosis of PML is essential for effective management.
  • Treatment strategies must be tailored to the patient's HIV status.
  • Ongoing research into novel therapies offers hope for improved PML outcomes.

More Related Videos

Multifocal Electroretinograms16:49

Multifocal Electroretinograms

Published on: December 4, 2011

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

Related Concept Videos

Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...